Electroconvulsive therapy in patients with vagus nerve stimulation

Ashish Sharma, Rajeev Chaturvedi, Arun Sharma, James H. Sorrell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Numerous studies have demonstrated the safety and efficacy of electroconvulsive therapy (ECT) for various psychiatric conditions, and it has been approved by the Food and Drug Administration for the treatment of refractory depression. Recently, the Food and Drug Administration also approved vagus nerve stimulation as a treatment for chronic or recurrent depression. Although electrical stimulation is used for both ECT and vagus nerve stimulation, the mechanisms of their action are very different. The American Psychiatric Association task force identifies no absolute contraindications to the use of ECT. The authors present 2 interesting cases of successful ECT in combination with vagus nerve stimulator.

Original languageEnglish (US)
Pages (from-to)141-143
Number of pages3
JournalJournal of ECT
Volume25
Issue number2
DOIs
StatePublished - Jun 1 2009

Fingerprint

Vagus Nerve Stimulation
Electroconvulsive Therapy
United States Food and Drug Administration
Treatment-Resistant Depressive Disorder
Vagus Nerve
Advisory Committees
Electric Stimulation
Psychiatry
Depression
Safety
Therapeutics

Keywords

  • Depression
  • ECT
  • VNS

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Psychiatry and Mental health

Cite this

Electroconvulsive therapy in patients with vagus nerve stimulation. / Sharma, Ashish; Chaturvedi, Rajeev; Sharma, Arun; Sorrell, James H.

In: Journal of ECT, Vol. 25, No. 2, 01.06.2009, p. 141-143.

Research output: Contribution to journalArticle

Sharma, Ashish ; Chaturvedi, Rajeev ; Sharma, Arun ; Sorrell, James H. / Electroconvulsive therapy in patients with vagus nerve stimulation. In: Journal of ECT. 2009 ; Vol. 25, No. 2. pp. 141-143.
@article{b06366ab06424db49ce5cd3f23a2804f,
title = "Electroconvulsive therapy in patients with vagus nerve stimulation",
abstract = "Numerous studies have demonstrated the safety and efficacy of electroconvulsive therapy (ECT) for various psychiatric conditions, and it has been approved by the Food and Drug Administration for the treatment of refractory depression. Recently, the Food and Drug Administration also approved vagus nerve stimulation as a treatment for chronic or recurrent depression. Although electrical stimulation is used for both ECT and vagus nerve stimulation, the mechanisms of their action are very different. The American Psychiatric Association task force identifies no absolute contraindications to the use of ECT. The authors present 2 interesting cases of successful ECT in combination with vagus nerve stimulator.",
keywords = "Depression, ECT, VNS",
author = "Ashish Sharma and Rajeev Chaturvedi and Arun Sharma and Sorrell, {James H.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1097/YCT.0b013e31817e8ab4",
language = "English (US)",
volume = "25",
pages = "141--143",
journal = "Journal of ECT",
issn = "1095-0680",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Electroconvulsive therapy in patients with vagus nerve stimulation

AU - Sharma, Ashish

AU - Chaturvedi, Rajeev

AU - Sharma, Arun

AU - Sorrell, James H.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Numerous studies have demonstrated the safety and efficacy of electroconvulsive therapy (ECT) for various psychiatric conditions, and it has been approved by the Food and Drug Administration for the treatment of refractory depression. Recently, the Food and Drug Administration also approved vagus nerve stimulation as a treatment for chronic or recurrent depression. Although electrical stimulation is used for both ECT and vagus nerve stimulation, the mechanisms of their action are very different. The American Psychiatric Association task force identifies no absolute contraindications to the use of ECT. The authors present 2 interesting cases of successful ECT in combination with vagus nerve stimulator.

AB - Numerous studies have demonstrated the safety and efficacy of electroconvulsive therapy (ECT) for various psychiatric conditions, and it has been approved by the Food and Drug Administration for the treatment of refractory depression. Recently, the Food and Drug Administration also approved vagus nerve stimulation as a treatment for chronic or recurrent depression. Although electrical stimulation is used for both ECT and vagus nerve stimulation, the mechanisms of their action are very different. The American Psychiatric Association task force identifies no absolute contraindications to the use of ECT. The authors present 2 interesting cases of successful ECT in combination with vagus nerve stimulator.

KW - Depression

KW - ECT

KW - VNS

UR - http://www.scopus.com/inward/record.url?scp=67849121872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67849121872&partnerID=8YFLogxK

U2 - 10.1097/YCT.0b013e31817e8ab4

DO - 10.1097/YCT.0b013e31817e8ab4

M3 - Article

VL - 25

SP - 141

EP - 143

JO - Journal of ECT

JF - Journal of ECT

SN - 1095-0680

IS - 2

ER -